Latest Advisories

  • FDA Advisory No. 2014-082 || product Recall of Lot Specific Hepatitis A Vaccine (Inactivated, Virosome) 24 IU/0.5 mL Solution for IM Injection with Brand Name EPAXAL

     

  • FDa Advisory No. 2014 || Reiteration of Publc Health Warning against The Use of Specific Batch (2412) of Purified Chick Embryo Cell Rabies Vaccine (Inactivated) 2.5 IU/mL Lyophilized Powder for Injection (ID/IM) (RABIPUR)

     

  • FDA Advisory No. 2014-080 || Public Warning against false, deceptive and misleading advertisement of My Jinga Juice posted in social media and the Internet

     

     

  • FDA Advisory No. 2014-079 || Voluntary Recall of Specific Batches of Arrowhead Mills Peanut Butter Products Distributed by Onestop Distribution and Healthy Options Corp

     

  • FDA Advisory No. 2014-078 || Product Recall of Lot Specific Rifampicin 450 mg Capsule (PICINAF)

     

In the interest of service, and for the information of all, the Food and Drug Administration (FDA) hereby adopts the Final Report of the 21 ASEAN Cosmetics Scientific Body (ACSB) and 21 ASEAN Cosmetic Committee (ACC) Correction in Annex III - Part I ref. No. 1a, column C point (b) "Products for all hygiene" to "Product for oral hygiene".

All company/ies or person/s responsible for placing the cosmetic product/s in the market are hereby advised to comply with this directive.

This order shall take effect immediately

SUBJECT : Administration of Customer Satisfaction Survey

In line with the intent to improve the FDA Services to its external and internal customers, there is a need to improve the collection of customer feedback

The FDA has established an administration of Customer Satisfaction Survey (CSS) to booth the internal and external FDA customers. A new color coded form will be used (white for external customers and green for internal customers), as well as new method  for administration and and collection will be instituted.

Effective 01 December 2014 the revised CSS form (see Annex A), together with the Visitor's ID pass, will be distributed by the Security Guards on duty to the external customers before entering FDA building. The accomplished survey form will be returned by the customers to the Security Guard on duty upon surrendering Visitor's ID pass.

For internal customers (FDA Employees) transacting business with the respective Centers and Offices, the accomplished CSS form shall be dropped in the box assigned per Center or Office. The accomplished CSS form shall be retrieved by the Policy and Planning Office at the end of each month.

For any question or clarification, please contact Policy and Planning Office at Telephone No. 857-1900 local 1111 or 1121 or via email (This email address is being protected from spambots. You need JavaScript enabled to view it.).

For strict compliance

Announcement

BAC ADVISORY NO. 2014-002
(ITB No. 14-019)

Construction of FDA Walkway, Waiting Shed, Steel Gate and Perimeter Fence

Subject : Re-Scheduled of PRE-BID CONFERENCE

09 December 2014

The PRE-BID CONFERENCE for the above subject project was not transpired on 08 December 2014 due to TYPHOON RUBY that caused work cancellation of all government offices in the National Capital Region (NCR).

In view thereof, all prospective bidders advised that the PRE-BID CONFERENCE is hereby re-scheduled on 11 December 2014 at 2:00pm, AFO Conference Room

For information and guidance of all concerned.

 

Announcement

  • Scheduled Delay in Processing of Electronic Cosmetic Product Notification

    ANNOUNCEMENT

    TO : All Cosmetics Manufacturer, Traders, Distributors and other concerned parties
    DATE : 19 November 2014
    SUBJECT : Scheduled Delay in Processing of Electronic Cosmetic Product Notification
                                         (Cosmetic e-Notification)
  • QPIRA ID for Release

    ANNOUNCEMENT

    DATE        : 10 November 2014
    TO            : ALL REGISTERED QUALIFIED PERSON IN
    INDUSTRY REGULATORY AFFAIRS (QPIRA)
    FROM        :  ATTY. RONALD R. DE VEYRA, MBA, CESO VI
     Acting Deputy Director General - AFO
    SUBJECT   : QPIRA ID for Release
  • Temporary Suspension of Procurement for ITB 14-017

     BAC ADVISORY 2014-001

    for ITB 14-017

    Procurement and Delivery of One (1) Year Locked in Period and Shall be Deemed Renewed until Terminated for Consumable Supply with Fifty (50) Units Complimentary Free Use of Printers 4 in 1 Monochrome

    This is to inform all prospective bidders that the Procurement and Delivery of One (1) Year Locked in Period and Shall be Deemed Renewed until Terminated for Consumable Supply with Fifty (50) Units Complimentary Free Use of Printers 4 in 1 Monochrome (ITB 14-017) is still undergoing review of technical specification and clarifications of other requirements thus the aforementioned project is indefinitely suspended until further notice.

    Thank you.

    Read more...
  • Announcement

    For ITB 14-015

    Procurement of Supply, Delivery, Installation, Configuration Testing, Infrastructure (Hardware and Software) for One Hundred (100) VDI Users

    During the 2nd pre-bid conference, on 31 October 2014, 11AM at AFO Conference Room, FDA-Main Bldg., Alabang, Muntinlupa City, the FDA BAC will discuss with you the size of the monitor needed by the FDA end users.

    Read more...
  • Public Hearing on the New Guideline on Medical Device Registration

    Public Hearing on the New Guideline on Medical Device Registration

    TO : Medical Device Industries
    When : 3 November 2014, 9:00 am - 12:00 pm
    Public Hearing on the New Guidelines on Medical Device Registration
    Where : 3/F, AVR, Annex Building Food and Drug Administration,
    Alabang, Muntinlupa City

    For efficiency, participants shall register online through This email address is being protected from spambots. You need JavaScript enabled to view it. with the following prescribed format below:

    Email Subject  Public Hearing on the New Guideline on Medical Device Registration
    Body of Email
    Name of Participant : Last Name, First Name, MI.
    Company Name  
    Contact No(s)  
    Email Address  

    A confirmation slip will be sent as a reply, please bring a copy of your confirmation slip on the day of Public Consultation

    For your information, guidance, and compliance

Videos

  • Win the War Againts AMR

    The misuse of antibiotics is creating resistant "superbugs" that may leave you or your family without effective treatment the next time antibiotics are needed.

  • FDA Public Assistance Information and Receiving (PAIR) Video Tutorial

    A step by step guide to filing an application for a License to Operate or a Certificate of Product Registration.
    By: Nicole Melanie Molera

  • Dr. Kenneth Hartigan-Go on Responsible Pharmaceutical Manufacturing by Interphil

    Dr. Kenneth Hartigan-Go talks about importance of CGMP in manufacturing pharmaceutical products, bioequivalence, importance of adverse drug monitoring, and ethical marketing communications.

Share Us on

Submit to FacebookSubmit to Google BookmarksSubmit to Twitter